Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28526 - 28550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	MEIS1	4211	upregulated	Cytarabine results in increased expression of MEIS1 mRNA	2p14	A21886
Cytarabine	Approved Investigational	MERTK	10461	downregulated	Cytarabine results in decreased expression of MERTK mRNA	2q13	A21886
Cytarabine	Approved Investigational	MFAP4	4239	downregulated	Cytarabine results in decreased expression of MFAP4 mRNA	17p11.2	A21886
Cytarabine	Approved Investigational	MGARP	84709	downregulated	Cytarabine results in decreased expression of MGARP mRNA	4q31.1	A21886
Cytarabine	Approved Investigational	MGP	4256	downregulated	Cytarabine results in decreased expression of MGP mRNA	12p12.3	A21886
Cytarabine	Approved Investigational	MIR22HG	84981	downregulated	Cytarabine results in decreased expression of MIR22HG mRNA	17p13.3	A21886
Cytarabine	Approved Investigational	MIR99AHG	388815	upregulated	Cytarabine results in increased expression of MIR99AHG mRNA	21q21.1	A21886
Cytarabine	Approved Investigational	MMP23B	8510	downregulated	Cytarabine results in decreased expression of MMP23B mRNA	1p36.33	A21886
Cytarabine	Approved Investigational	MPP6	51678	downregulated	Cytarabine results in decreased expression of MPP6 mRNA	7p15.3	A21886
Cytarabine	Approved Investigational	MPZL1	9019	downregulated	Cytarabine results in decreased expression of MPZL1 mRNA	1q24.2	A21886
Cytarabine	Approved Investigational	MSX1	4487	downregulated	Cytarabine results in decreased expression of MSX1 mRNA	4p16.2	A21886
Cytarabine	Approved Investigational	MT1A	4489	downregulated	Cytarabine results in decreased expression of MT1A mRNA	16q13	A21886
Cytarabine	Approved Investigational	MT1E	4493	downregulated	Cytarabine results in decreased expression of MT1E mRNA	16q13	A21886
Cytarabine	Approved Investigational	MT1IP	644314	downregulated	Cytarabine results in decreased expression of MT1IP mRNA	16q13	A21886
Cytarabine	Approved Investigational	MT1P3	140851	downregulated	Cytarabine results in decreased expression of MT1P3 mRNA	20q11.22	A21886
Cytarabine	Approved Investigational	MT1X	4501	downregulated	Cytarabine results in decreased expression of MT1X mRNA	16q13	A21886
Cytarabine	Approved Investigational	MT2A	4502	downregulated	Cytarabine results in decreased expression of MT2A mRNA	16q13	A21886
Cytarabine	Approved Investigational	MTUS1	57509	upregulated	Cytarabine results in increased expression of MTUS1 mRNA	8p22	A21886
Cytarabine	Approved Investigational	MVB12A	93343	downregulated	Cytarabine results in decreased expression of MVB12A mRNA	19p13.11	A21886
Cytarabine	Approved Investigational	MXD3	83463	upregulated	Cytarabine results in increased expression of MXD3 mRNA	5q35.3	A21886
Cytarabine	Approved Investigational	MXRA7	439921	downregulated	Cytarabine results in decreased expression of MXRA7 mRNA	17q25.1	A21886
Cytarabine	Approved Investigational	MYADM	91663	downregulated	Cytarabine results in decreased expression of MYADM mRNA	19q13.42	A21886
Cytarabine	Approved Investigational	MYDGF	56005	downregulated	Cytarabine results in decreased expression of MYDGF mRNA	19p13.3	A21886
Cytarabine	Approved Investigational	MYL4	4635	downregulated	Cytarabine results in decreased expression of MYL4 mRNA	17q21.32	A21886
Cytarabine	Approved Investigational	MYL7	58498	downregulated	Cytarabine results in decreased expression of MYL7 mRNA	7p13	A21886

Displaying entries 28526 - 28550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability